Skip to content
ppharmaranks
Menu

robitussin dm

Robitussin Dm is a combination medicine containing Dextromethorphan and Guaifenesin.

Dextromethorphan and Guaifenesin

Not yet rated· sourced from the FDA label
Rated against independent regulatory sources·Last updated June 28, 2026·How we rate
Verified againstopenFDANIH DailyMedRxClass
Check price on Amazon →We may earn a commission · never affects ratings

Key facts

Active ingredient
Dextromethorphan and Guaifenesin
Form
Liquid
Type
Over-the-counter (OTC)
Brand or generic
Brand-name

Dosage forms

Liquid

The forms currently marketed in the U.S., per the FDA National Drug Code Directory.

Ways to save

Ask for the generic

Same active ingredient, far cheaper. Is there a generic? →

Request a 90-day supply

Bulk fills usually lower the per-dose price vs monthly refills.

Use copay cards

Manufacturer copay cards & patient-assistance programs — especially for brand drugs.

Compare alternatives

A same-class option may cost less. See alternatives →

Frequently asked questions

Is there a coupon or discount for Robitussin Dm?
pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Robitussin Dm. To pay less, look for a store-brand version with the same active ingredient (Dextromethorphan and Guaifenesin), which is typically cheaper, and compare unit prices. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
Is Robitussin Dm a brand-name or generic drug?
Robitussin Dm is a brand-name product with the active ingredient Dextromethorphan and Guaifenesin.
Is Robitussin Dm available over the counter?
Yes. Robitussin Dm is an over-the-counter (OTC) product — you can buy it without a prescription. Follow the label directions and ask a pharmacist if you're unsure whether it's right for you.
What forms does Robitussin Dm come in?
Robitussin Dm is currently marketed as liquid, per the FDA's National Drug Code Directory.

Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.

What people report to the FDA about Dextromethorphan and guaifenesin

The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 2 reports naming Dextromethorphan and guaifenesin — the active ingredient in Robitussin Dm, and the FDA flagged 100% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:

  • abdominal injury1 reports
  • abdominal pain1 reports
  • adverse event1 reports
  • agitation1 reports
  • anxiety1 reports
  • atrial fibrillation1 reports
  • bipolar disorder1 reports
  • blood calcium decreased1 reports

Read these as a signal, not a rate. A report does not mean Dextromethorphan and guaifenesin caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.

Source: openFDA drug/event (FAERS), retrieved September 25, 2026.

Reviews

No reviews yet. Be the first to write one.

Write a review

Reviews are user opinions, not medical advice. Consult a licensed professional.

People also viewed

Compare Robitussin Dm head-to-head

Identify a pill by its imprint →Check a drug interaction →Drug recalls →

Browse medications A–Z

Research products from A to Z, compare independent ratings, and find alternatives.